Renal oxygenation in clinical acute kidney injury

Critical Care

Volumn 17, Issue 2, 2013, Pages

  Ricksten, Sven Erik ^a   Bragadottir, Gudrun ^a   Redfors, Bengt ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DIURETIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FUROSEMIDE; OXYGEN; SODIUM;

ACUTE KIDNEY FAILURE; BOLD SIGNAL; CARDIOVASCULAR SURGERY; CREATININE CLEARANCE; DIURETIC THERAPY; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; HYPOXIA; KIDNEY MEDULLA; KIDNEY OXYGEN CONSUMPTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; OXYGENATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RENAL OXYGENATION; RENAL PROTECTION; REVIEW; SODIUM ABSORPTION; SODIUM EXCRETION; SURGICAL PATIENT; ACUTE KIDNEY INJURY; ANIMAL; KIDNEY CIRCULATION; METABOLISM; PHYSIOLOGY; POSTOPERATIVE CARE; PROCEDURES;

ACUTE KIDNEY INJURY; ANIMALS; GLOMERULAR FILTRATION RATE; HUMANS; OXYGEN CONSUMPTION; POSTOPERATIVE CARE; RENAL CIRCULATION;

EID: 84875371558     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12530     Document Type: Review

References (61)

1. Zäll S, Milocco I, Ricksten SE. Effects of adenosine on myocardial blood flow and metabolism after coronary artery bypass surgery. Anesth Analg 1991, 73:689-695.
2. Redfors B, Bragadottir G, Sellgren J, Swärd K, Ricksten SE. Acute renal failure is NOT an "acute renal success" - a clinical study on the renal oxygen supply/demand relationship in acute kidney injury. Crit Care Med 2010, 38:1695-1701. 10.1097/CCM.0b013e3181e61911, 20512036.
3. Kiil F, Aukland K, Refsum HE. Renal sodium transport and oxygen consumption. Am J Physiol 1961, 201:511-516.
4. Torelli G, Milla E, Faelli A, Costantini S. Energy requirement for sodium reabsorption in the in vivo rabbit kidney. Am J Physiol 1966, 211:576-580.
5. Swärd K, Valsson F, Sellgren J, Ricksten SE. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med 2004, 31:79-85.
6. Redfors B, Swärd K, Sellgren J, Ricksten SE. Effects of mannitol alone and mannitol plus furosemide on renal oxygen consumption, blood flow and glomerular filtration after cardiac surgery. Intensive Care Med 2009, 35:115-122. 10.1007/s00134-008-1206-5, 18612627.
7. Bragadottir G, Redfors B, Nygren A, Sellgren J, Ricksten SE. Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients. Acta Anaesthesiol Scand 2009, 53:1052-1059. 10.1111/j.1399-6576.2009.02037.x, 19572935.
8. O'Connor PM. Renal oxygen delivery: matching delivery to metabolic demand. Clin Exp Pharmacol Physiol 2006, 33:961-967. 10.1111/j.1440-1681.2006.04475.x, 17002675.
9. Levy MN. Effect of variations of blood flow on renal oxygen extraction. Am J Physiol 1960, 199:13-18.
10. Chou SY, Porush JG, Faubert PF. Renal medullary circulation: hormonal control. Kidney Int 1990, 37:1-13. 10.1038/ki.1990.1, 2137185.
11. Brezis M, Rosen S. Hypoxia of the renal medulla - its implications for disease. N Engl J Med 1995, 332:647-655. 10.1056/NEJM199503093321006, 7845430.
12. Aukland K, Johannesen J, Kiil F. In vivo measurements of local metabolic rate in the dog kidney. Effect of mersalyl, chlorothiazide, ethacrynic acid and furosemide. Scand J Clin Lab Invest 1969, 23:317-330. 10.3109/00365516909081697, 5383314.
13. Kramer HJ, Schuurmann J, Wassermann C, Dusing R. Prostaglandin-independent protection by furosemide from oliguric ischaemic renal failure in conscious rats. Kidney Int 1980, 17:455-464. 10.1038/ki.1980.53, 7392420.
14. Bayati A, Nygren K, Kallskog O, Wolgast M. The effect of loop diuretics on the long-term outcome of post-ischaemic acute renal failure in the rat. Acta Physiol Scand 1990, 139:271-279. 10.1111/j.1748-1716.1990.tb08924.x, 2368616.
15. Shilliday I, Allison ME. Diuretics in acute renal failure. Ren Fail 1994, 16:3-17. 10.3109/08860229409044843, 8184144.
16. Prasad PV, Edelman RR, Epstein FH. Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation 1996, 94:3271-3275. 10.1161/01.CIR.94.12.3271, 8989140.
17. Cupples WA, Braam B. Assessment of renal autoregulation. Am J Physiol Renal Physiol 2007, 292:F1105-F11223.
18. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000, 11:97-104.
19. Jones D, Bellomo R. Renal-dose dopamine: from hypothesis to paradigm to dogma to myth and, finally, superstition?. J Intensive Care Med 2005, 20:199-211. 10.1177/0885066605276963, 16061903.
20. Marik PE. Low-dose dopamine: a systematic review. Intensive Care Med 2002, 28:877-883. 10.1007/s00134-002-1346-y, 12122525.
21. Woo EB, Tang AT, el-Gamel A, Green halgh D, Patrick M, Jones MT, Hooper TL. Dopamine therapy for patients at risk of renal dysfunction following cardiac surgery: science or fiction?. Eur J Cardiothorac Surg 2002, 22:106-111. 10.1016/S1010-7940(02)00246-4, 12103382.
22. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomized trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000, 356:2139-2143.
23. Redfors B, Bragadottir G, Sellgren J, Swärd K, Ricksten SE. Dopamine increases renal oxygenation: a clinical study in post-cardiac surgery patients. Acta Anaesthesiol Scand 2010, 54:183-190. 10.1111/j.1399-6576.2009.02121.x, 19764906.
24. Edwards RM. Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro. Eur J Pharmacol 1986, 126:167-170. 10.1016/0014-2999(86)90756-9, 2875883.
25. Mathur VS, Swan SK, Anjum S, Lambrecht LJ, Anjum S, Fellmann J, McGuire D, Epsein M, Luther RR. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 1999, 27:1832-1837. 10.1097/00003246-199909000-00021, 10507606.
26. Halpenny M, Rushe C, Breen P, Cunningham AJ, Boucher-Hayes D, Shorten GD. The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. Eur J Anaesthesiol 2002, 19:32-39.
27. Cogliati AA, Vellutini R, Nardini A, Urovi S, Hamdan M, Landoni G, Guelfi P. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. J Cardiothorac Vasc Anesth 2007, 21:847-850. 10.1053/j.jvca.2007.02.022, 18068064.
28. Bove T, Landoni G, Calabrò MG, Aletti G, Marino G, Cerchierini E, Crescenzi G, Zangrillo A. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation 2005, 111:3230-3235. 10.1161/CIRCULATIONAHA.104.509141, 15967861.
29. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998, 128:194-203.
30. Englberger L, Suri RM, Li Z, Casey ET, Daily RC, Dearani HA, Schaff HV. Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit Care 2011, 15:R16. 10.1186/cc9960, 3222049, 21232094.
31. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004, 15:1597-1605. 10.1097/01.ASN.0000130340.93930.DD, 15153571.
32. Kanji HD, Schulze CJ, Hervas-Malo M, Wang P, Ross DB, Zibdawi M, Bagshaw SM. Difference between pre-operative and cardiopulmonary bypass mean arterial pressure is independently associated with early cardiac surgery-associated acute kidney injury. J Cardiothorac Surg 2010, 5:71. 10.1186/1749-8090-5-71, 2941753, 20825657.
33. Thurau K, Boylan JW. Acute renal success. The unexpected logic of oliguria in acute renal failure. Am J Med 1976, 61:308-315. 10.1016/0002-9343(76)90365-X, 961698.
34. Rosenberger C, Rosen S, Heyman SN. Renal parenchymal oxygenation and hypoxia adaptation in acute kidney injury. Clin Exp Pharmacol Physiol 2006, 33:980-988. 10.1111/j.1440-1681.2006.04472.x, 17002677.
35. Molitoris BA, Falk SA, Dahl RH. Ischemia-induced loss of epithelial polarity. Role of the tight junction. J Clin Invest 1989, 84:1334-1339. 10.1172/JCI114302, 329795, 2551926.
36. Molitoris BA. Na(+)-K(+)-ATPase that redistributes to apical membrane during ATP depletion remains functional. Am J Physiol 1993, 265:F693-697.
37. Laycock SK, Vogel T, Forfia PR, Tuzman J, Xu X, Ochoa M, Thompson CI, Nasjetti A, Hintze TH. Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ Res 1998, 82:1263-1271. 10.1161/01.RES.82.12.1263, 9648722.
38. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994, 345:50-54. 10.1016/0014-5793(94)00424-2, 8194600.
39. Valsson F, Ricksten SE, Hedner T, Lundin S. Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery. Intensive Care Med 1996, 22:230-236. 10.1007/BF01712242, 8727437.
40. Sward K, Valsson F, Odencrants P, Samuelsson O, Ricksten SE. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med 2004, 32:1310-1315. 10.1097/01.CCM.0000128560.57111.CD, 15187512.
41. Burke TJ, Cronin RE, Duchin KL, Peterson LN, Schrier RW. Ischemia and tubule obstruction during acute renal failure in dogs: mannitol in protection. Am J Physiol 1980, 238:F305-F314.
42. Valdes ME, Landau SE, Shah DM, Newell JC, Scovill WA, Stratton H, Rhodes GR, Powers SR. Increased glomerular filtration rate following mannitol administration in man. J Surg Res 1979, 26:473-477. 10.1016/0022-4804(79)90036-2, 439878.
43. Molitoris BA, Sandoval R, Sutton TA. Endothelial injury and dysfunction in ischemic acute renal failure. Crit Care Med 2002, 30:S235-S240. 10.1097/00003246-200205001-00011, 12004242.
44. Bragadottir G, Redfors B, Ricksten SE. Mannitol increases renal blood flow and maintains filtration fraction and oxygenation in postoperative acute kidney injury - a prospective interventional study. Crit Care 2012, 16:R159. 10.1186/cc11480, 3580749, 22901953.
45. Kristof AS, Magder S. Low systemic vascular resistance in patients undergoing cardiopulmonary bypass. Crit Care Med 1999, 27:1121-1127. 10.1097/00003246-199906000-00033, 10397216.
46. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med 2008, 34:17-60. 10.1007/s00134-007-0934-2, 2249616, 18058085.
47. Redfors B, Bragadottir G, Sellgren J, Sward K, Ricksten SE. Effects of norepinephrine on renal perfusion, filtration and oxygenation in vasodilatory shock and acute kidney injury. Intensive Care Med 2011, 37:60-67. 10.1007/s00134-010-2057-4, 20949349.
48. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001, 345:588-595. 10.1056/NEJMra002709, 11529214.
49. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997, 25:1279-1282. 10.1097/00003246-199708000-00012, 9267938.
50. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002, 96:576-582. 10.1097/00000542-200203000-00011, 11873030.
51. ter Wee PM, Smit AJ, Rosman JB, Sluiter WJ, Donker AJ. Effect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal disease. Am J Nephrol 1986, 6:42-46. 10.1159/000167051, 3963058.
52. Schoors DF, Dupont AG. Further studies on the mechanism of the natriuretic response to low-dose dopamine in man: effect on lithium clearance and nephrogenic cAMP formation. Eur J Clin Invest 1990, 20:385-391.
53. Olsen NV, Lund J, Jensen PF, Espersen K, Kanstrup IL, Plum I, Leyssac PP. Dopamine, dobutamine, and dopexamine. A comparison of renal effects in unanesthetized human volunteers. Anesthesiology 1993, 79:685-594. 10.1097/00000542-199310000-00009, 8105728.
54. Olsen NV, Hansen JM, Kanstrup IL, Richalet JP, Leyssac PP. Renal hemodynamics, tubular function, and response to low-dose dopamine during acute hypoxia in humans. J Appl Physiol 1993, 74:2166-2173.
55. Olsen NV, Lang-Jensen T, Hansen JM, Plum I, Thomsen JK, Strangaard S, Leyssac PP. Effects of acute beta-adrenoceptor blockade with metoprolol on the renal response to dopamine in normal humans. Br J Clin Pharmacol 1994, 37:347-353. 10.1111/j.1365-2125.1994.tb04288.x, 1364735, 8018456.
56. Richer M, Robert S, Lebel M. Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man. Crit Care Med 1996, 24:1150-1156. 10.1097/00003246-199607000-00014, 8674327.
57. Mc Donald RH, Goldberg LI, McNay JL, Tuttle EP. Effect of dopamine in man: Augmentation of sodium excretion, glomerular filtration rate and renal plasma flow. J Clin Invest 1964, 43:1116-1124. 10.1172/JCI104996, 289593, 14171789.
58. Rosenblum R, Tai AR, Lawson D. Dopamine in man: cardiorenal hemodynamics in normotensive patients with heart disease. J Pharmacol Exp Ther 1972, 183:256-263.
59. Schwartz LB, Bissell MG, Murphy M, Gewertz BL. Renal effects of dopamine in vascular surgical patients. J Vasc Surg 1988, 8:367-374.
60. Graves TA, Cioffi WG, Vaughan GM, Pratt L, Heironimus JD, McManus WF, Pruitt BA. The renal effects of low-dose dopamine in thermally injured patients. J Trauma 1993, 35:97-102. 10.1097/00005373-199307000-00016, 8331720.
61. Ungar A, Fumagalli S, Marini M, Di Serio C, Taranti F, Boncinelli G, Valoti P, La Cava G, Oliani C, Masotti G, Marchionni N. Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure. Crit Care Med 2004, 32:1125-1129. 10.1097/01.CCM.0000124871.58281.D1, 15190961.